| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRI | Common Stock | Options Exercise | $745,675 | +17,500 | +4.1% | $42.61 | 448,910 | 22 Nov 2021 | Direct | F1, F2 |
| transaction | CRI | Common Stock | Sale | $1,845,375 | -17,500 | -3.9% | $105.45 | 431,410 | 22 Nov 2021 | Direct | F1, F2, F3 |
| transaction | CRI | Common Stock | Sale | $1,260,438 | -12,072 | -2.8% | $104.41 | 419,338 | 22 Nov 2021 | Direct | F1, F2, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRI | Employee Stock Option (Right to Purchase) | Options Exercise | $0 | -17,500 | -50% | $0.000000 | 17,500 | 22 Nov 2021 | Common Stock | 17,500 | $42.61 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | The transaction reported in this Form 4 was effectuated pursuant to a Rule 10b5-1 trading plan |
| F2 | Some of these shares are restricted shares that are subject to either time-vesting or performance-based restrictions. |
| F3 | This is a weighted average price. The shares were sold in multiple trade executions at prices ranging from $104.71 to $107.50 inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| F4 | This is a weighted average price. The shares were sold in multiple trade executions at prices ranging from $104.15 to $105.00 inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| F5 | The option vested in four equal installments on February 22, 2013, 2014, 2015, and 2016. |